Primary adrenal insufficiency due to adrenal tuberculosis: a case report

We report a case of primary adrenal insufficiency (PAI) due to adrenal tuberculosis with no findings of active tuberculosis in the lung of a 51-year-old female patient. The patient was admitted with a 10-year history of skin hyperpigmentation and was diagnosed with PAI. The primary cause was adrenal tuberculosis. An adrenocorticotropic hormone stimulation test, T-Spot test and adrenal computed tomography scan were used to confirm the diagnosis. The patient’s status improved, and the hyperpigmentation subsided after 15 months of treatment with anti-tuberculosis drugs and cortisol replacement therapy.

[1]  Jie Zheng,et al.  Clinical effect of T-SPOT.TB test for the diagnosis of tuberculosis , 2019, BMC infectious diseases.

[2]  Kui Liu,et al.  Public Awareness of Tuberculosis in Southeast China: A Population-Based Study , 2019, International journal of environmental research and public health.

[3]  L. Fan,et al.  Evaluation of risk factors for false-negative results with an antigen-specific peripheral blood-based quantitative T cell assay (T-SPOT®.TB) in the diagnosis of active tuberculosis: A large-scale retrospective study in China , 2018, The Journal of international medical research.

[4]  H. Sugiyama,et al.  Sensitivity and specificity of QuantiFERON-TB Gold Plus compared with QuantiFERON-TB Gold In-Tube and T-SPOT.TB on active tuberculosis in Japan. , 2017, Journal of infection and chemotherapy : official journal of the Japan Society of Chemotherapy.

[5]  P. Zelissen,et al.  Adrenal Crisis: Still a Deadly Event in the 21st Century. , 2016, The American journal of medicine.

[6]  K. Higuchi,et al.  Comparison of specificities between two interferon-gamma release assays in Japan. , 2012, The international journal of tuberculosis and lung disease : the official journal of the International Union against Tuberculosis and Lung Disease.

[7]  K. Higuchi,et al.  Comparison of specificities between two interferon-gamma release assays in Japan [Short communication]. , 2012, The International Journal of Tuberculosis and Lung Disease.

[8]  T. Barkham,et al.  Comparison of Sensitivities of Two Commercial Gamma Interferon Release Assays for Pulmonary Tuberculosis , 2008, Journal of Clinical Microbiology.

[9]  K. Lam,et al.  A critical examination of adrenal tuberculosis and a 28‐year autopsy experience of active tuberculosis , 2001, Clinical endocrinology.